🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Wen-I Yeh

Fate Therapeutics (United States)

ORCID: 0000-0002-5705-4232

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “CD226 Deletion Reduces Type 1 Diabetes in the NOD Mouse by Impairing Thymocyte Development and Peripheral T Cell Activation”.

CD226 Deletion Reduces Type 1 Diabetes in the NOD Mouse by Impairing Thymocyte Development and Peripheral T Cell Activation

Frontiers in Immunology(2020)10.3389/fimmu.2020.02180

N/A

0DataRank · unranked

34 citations

Wen-I Yeh, Joshua R. Longfield, John T. Gallagher, Caridad M. Infante, Sarah Wellford +9 more

Deletion of CD226 in Foxp3 + T cells Reduces Diabetes Incidence in Non-Obese Diabetic Mice by Improving Regulatory T Cell Stability and Function

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.02.494443

N/A

0DataRank · unranked

0 citations

Matthew E. Brown, Lindsey K. Sachs, Juan M. Arnoletti, Wen-I Yeh, Amanda L. Posgai +4 more

A chimeric antigen receptor uniquely recognizing MICA/B stress proteins provides an effective approach to target solid tumors

Med(2023)10.1016/j.medj.2023.04.004

N/A

0DataRank · unranked

25 citations

Wen-I Yeh, Bryan Hancock, Robert Blum, Tianhao Xu, Bi-Huei Yang +22 more